benextramine has been researched along with Affective Disorders in 1 studies
benextramine: RN given refers to parent cpd
| Excerpt | Relevance | Reference |
|---|---|---|
| " Compound 15 was identified as a selective and high affinity NPY5 antagonist with good oral bioavailability in mice (42%) and rats (92%)." | 1.37 | Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder. ( Andersen, K; Chandrasena, G; Desai, M; Jubian, V; Lu, Y; Marzabadi, MR; Noble, SA; Packiarajan, M; Walker, MW; Wiborg, O; Wolinsky, TD; Wong, WC; Zhong, H, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Packiarajan, M | 1 |
| Marzabadi, MR | 1 |
| Desai, M | 1 |
| Lu, Y | 1 |
| Noble, SA | 1 |
| Wong, WC | 1 |
| Jubian, V | 1 |
| Chandrasena, G | 1 |
| Wolinsky, TD | 1 |
| Zhong, H | 1 |
| Walker, MW | 1 |
| Wiborg, O | 1 |
| Andersen, K | 1 |
1 other study available for benextramine and Affective Disorders
| Article | Year |
|---|---|
Discovery of Lu AA33810: a highly selective and potent NPY5 antagonist with in vivo efficacy in a model of mood disorder.
Topics: Animals; Benzothiepins; Biological Availability; Disease Models, Animal; Dose-Response Relationship, | 2011 |